• Poster

A Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-to-Severe Psoriasis

Citation

Odom, D., Brogan, A. J., Talbird, S. E., & Schenkel, B. (2013, June). A Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-to-Severe Psoriasis. Presented at ISPOR 18th Annual International Meeting, .

Abstract